But there is still more:
Febr. 11, 2004: "Today marks the beginning of a 90 patient, multicenter Phase II trial of PI-88 in combination with Taxotere® for the second-line treatment of advanced non-small cell lung cancer (NSCLC)".
So, Phase II Myeloma has been completed and currently there are 2 more Phase II trials going: Melanoma and NSCLC.
Gerry
drug pi-88, melanoma; how good is it?, page-2
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.46M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 44.0¢ | $14.12K | 32.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 773989 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 37049 | 4 |
View Market Depth
| Last trade - 13.26pm 10/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |